PW241 The Cost-Effectiveness of Guideline-Driven Use of Drug-Eluting Stents in Victorian Public Hospitals

O ST E R A B ST R A C T S care in the delivery of medical interventions. Cardiovascular interventions including Percutaneous Coronary Intervention (PCI) are high cost activities that have become widely adopted across the region. Registries in individual institutions and countries are valuable, however, the establishment of a collaboration across the Asia Pacific Region to inform on variations in patient and procedural characteristics and associated clinical outcomes would enable regional benchmarking of quality performance. Objectives: An inaugural Asia Pacific Evaluation of Cardiovascular Therapies (ASPECT) Collaboration meeting was held in Singapore in July 2012 with 27 hospital representatives attending. The proposed aims of the collaboration included a) to identify the characteristics of patients undergoing PCI across the Asia Pacific region, b) to report on outcomes of patients undergoing PCI across the Asia Pacific Region, c) to develop an appropriate ethnic specific risk adjustment model for patients undergoing PCI across the Asia Pacific Region and d) to establish a registry framework for research, education and training in the area of cardiovascular interventions across the Asia Pacific Region. Methods: Following agreement, common fields were identified from data sets of existing local registries and an initial report on patient characteristics across the region was proposed. Descriptive characteristics of patients undergoing PCI over a 12 month period were collated and reported. Results: In every country, males predominated PCI activity. Subjects were older and had higher rates of family history of cardiovascular disease in Australia, while Asian subjects had higher rates of diabetes, dyslipidaemia and renal failure. STEMI presentation was higher in Australia than in Asia and Drug eluting stent use was higher in Asia. Procedural success rates were similar across the region (>95%). Conclusion: Resolution of cross border individual patient data transfer and collation of pooled data in a central registry is ongoing. Patient characteristics differ across countries in Asia in terms of pre-procedural risk factors and clinical presentation, however procedural success was similar. Impact on patient outcomes at 30 days and longer term outcomes are being assessed. Disclosure of Interest: None Declared